Primary Study to Demonstrate Non-inferiority and Immunogenicity of GSK Biologicals' Meningococcal Vaccine 134612

NCT00465816 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

611

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Meningococcal

Interventions

BIOLOGICAL: Nimenrix (Meningococcal vaccine 134612)
BIOLOGICAL: Twinrix

Sponsor

GlaxoSmithKline